Industrial & SMB robotPilot only
Fourier GR-3
The first humanoid designed to care rather than to carry.
We haven't tested this machine hands-on, so this profile carries no rating — every fact below traces to the sources at the end, and the judgments are clearly ours. Full methodology on the Robot Tracker.
At a glance
- Status
- Pilot onlyWorking in partner facilities — you can't buy one
- Can you buy it?
- Yes
- Price
- From above ¥200,000 (~$28,000), B2B pre-sales
- Form factor
- Bipedal humanoid (care-focused)
- AI brain
- In-house full-perception multimodal system + LLM reasoning
- Maker
- Fourier (China)
- Backing
- Private; ~$110M Series E (2025), backed by Guoxin and Prosperity7
Shanghai's Fourier took the road nobody else on this tracker chose: instead of warehouse totes, its third-generation humanoid GR-3 is built for care — eldercare facilities, rehab centers, hospitals, and companionship. The 165 cm, 55-degree-of-freedom 'care-bot' pairs multimodal perception (vision, audio, touch) with LLM reasoning for emotionally aware interaction, and hot-swappable batteries for round-the-clock service. Priced above ¥200,000 (~$28,000), it's aimed at institutions, with B2B pre-sales open and early clinical integrations reported in 2026.
Fourier's credibility comes from its day job: it's a rehabilitation-robotics company whose devices are deployed in 2,000+ institutions across 40+ countries, and its GR-1 was China's first mass-produced humanoid. A company that already sells into hospitals building a humanoid for hospitals is a fundamentally more plausible story than a demo-reel startup discovering healthcare. It also debuted a doll-sized GR-3 variant at CES 2026 aimed at home companionship — the closest any serious humanoid maker has come to our beat.
What's real
- • The only major humanoid designed care-first — emotional interaction, eldercare, and rehab rather than logistics
- • Real healthcare distribution: Fourier's rehab devices already serve 2,000+ institutions in 40+ countries
- • Practical service engineering (hot-swap batteries, ~3 h runtime) and a genuinely disruptive B2B price (~$28k+)
Know before you watch (or buy)
- • Early: B2B pre-sales and pilot clinical integrations, not proven at-scale deployments
- • Care robotics carries the highest safety and trust bar in the industry — evidence of real eldercare outcomes doesn't exist yet for any humanoid
- • Consumer/home versions are announcements (the CES 2026 mini variant), not products
The evidence
B2B pre-sales open; early clinical-setting integrations reported (2026); parent company's rehab products deployed in 2,000+ institutions across 40+ countries.
Bottom line
The humanoid whose thesis is closest to this site's: machines for human connection and care. Fourier's hospital distribution makes it the credible contender in care robotics — but 'designed to care' remains a design goal, not yet a verified outcome. Watch the clinical pilots.
FAQ
What is the Fourier GR-3 for?
Care settings: eldercare facilities, hospitals, rehabilitation centers, education, and interactive companionship. It's a 165 cm humanoid with multimodal perception and LLM-driven interaction, priced above ¥200,000 (~$28,000) for B2B buyers, with pre-sales open and early clinical integrations reported. It is not a consumer product yet, though a smaller home-oriented variant was previewed at CES 2026.